SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009714
Filing Date
2020-08-06
Accepted
2020-08-06 17:08:09
Documents
80
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20200630x10q.htm   iXBRL 10-Q 1997860
2 EX-10.2 kala-20200630xex10d2.htm EX-10.2 66096
3 EX-10.3 kala-20200630xex10d3.htm EX-10.3 77272
4 EX-31.1 kala-20200630xex31d1.htm EX-31.1 15203
5 EX-31.2 kala-20200630xex31d2.htm EX-31.2 15163
6 EX-32.1 kala-20200630xex32d1.htm EX-32.1 6697
7 EX-32.2 kala-20200630xex32d2.htm EX-32.2 6796
  Complete submission text file 0001558370-20-009714.txt   7421822

Data Files

Seq Description Document Type Size
8 EX-101.SCH kala-20200630.xsd EX-101.SCH 52246
9 EX-101.CAL kala-20200630_cal.xml EX-101.CAL 44970
10 EX-101.DEF kala-20200630_def.xml EX-101.DEF 197542
11 EX-101.LAB kala-20200630_lab.xml EX-101.LAB 460016
12 EX-101.PRE kala-20200630_pre.xml EX-101.PRE 364134
13 EXTRACTED XBRL INSTANCE DOCUMENT kala-20200630x10q_htm.xml XML 1152812
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 201082676
SIC: 2834 Pharmaceutical Preparations